Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Clinical Pharmacy
|
November 1, 1983
Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children
M D Reed, H L Rekate, S C Aronoff, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1984
Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients
M D Reed, C A O'Brien, S C Aronoff, et al.
Clinical Pharmacy
|
March 1, 1982
Evaluation of moxalactam
M D Reed, J S Bertino, S C Aronoff, et al.
Chemotherapy
|
January 1, 1984
Evaluation of latamoxef as initial therapy of bone and joint infections in childhood
S C Aronoff, P V Scoles, M D Reed, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 5, 1999
Reduced interleukin-8 production by cystic fibrosis airway epithelial cells
A R Massengale, F Quinn, J Yankaskas, et al.
Reviews of Infectious Diseases
|
November 1, 1986
Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children
S C Aronoff, P V Scoles, J T Makley, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1983
Efficacy and safety of ceftriaxone in serious pediatric infections
S C Aronoff, D Murdell, C A O'Brien, et al.
Pediatric Research
|
April 1, 1988
The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis
C J Dickinson, M D Reed, R C Stern, et al.
Journal of Pediatric Surgery
|
September 1, 1987
Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis
S C Aronoff, M M Olson, M W Gauderer, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1983
Developmental pharmacokinetics of moxalactam
M D Reed, S C Aronoff, C M Myers, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Clinical Pharmacy
|
November 1, 1983
Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children
M D Reed, H L Rekate, S C Aronoff, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1984
Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients
M D Reed, C A O'Brien, S C Aronoff, et al.
Clinical Pharmacy
|
March 1, 1982
Evaluation of moxalactam
M D Reed, J S Bertino, S C Aronoff, et al.
Chemotherapy
|
January 1, 1984
Evaluation of latamoxef as initial therapy of bone and joint infections in childhood
S C Aronoff, P V Scoles, M D Reed, et al.
American Journal of Respiratory Cell and Molecular Biology
|
May 5, 1999
Reduced interleukin-8 production by cystic fibrosis airway epithelial cells
A R Massengale, F Quinn, J Yankaskas, et al.
Reviews of Infectious Diseases
|
November 1, 1986
Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children
S C Aronoff, P V Scoles, J T Makley, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1983
Efficacy and safety of ceftriaxone in serious pediatric infections
S C Aronoff, D Murdell, C A O'Brien, et al.
Pediatric Research
|
April 1, 1988
The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis
C J Dickinson, M D Reed, R C Stern, et al.
Journal of Pediatric Surgery
|
September 1, 1987
Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis
S C Aronoff, M M Olson, M W Gauderer, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1983
Developmental pharmacokinetics of moxalactam
M D Reed, S C Aronoff, C M Myers, et al.
Page
of 6